Literature DB >> 9305185

Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance.

K Dobashi1, K Sugio, T Osaki, T Oka, K Yasumoto.   

Abstract

OBJECTIVES: Approximately one fourth of all patients with stage I non-small-cell lung cancer die of tumor recurrence, despite radical removal of their tumors. We thus tried to detect micrometastasis in the regional lymph nodes indicated to be tumor free by conventional histopathologic methods in patients with non-small-cell lung cancer by using immunohistochemical staining for p53 protein. We also investigated the relation between micrometastatic p53-positive cells in the lymph nodes and the prognosis of the patients.
METHODS: Samples from 480 regional lymph nodes were taken from 47 patients who underwent pulmonary resection for non-small-cell lung cancer and whose primary lesions were positive for p53 immunohistochemical staining. These samples were fixed in formalin and embedded in paraffin. We used p53 immunohistochemical staining to detect micrometastatic tumor cells in the lymph nodes.
RESULTS: Cells positive for p53 protein were found in 14 of 31 (45%) patients with a negative pathologic lymph node status and in 26 of 315 (8.3%) lymph nodes in these patients. The proportion of patients with micrometastasis who survived was also significantly lower than the proportion of patients without micrometastasis who survived (p = 0.0001).
CONCLUSIONS: Immunohistochemical staining for the p53 protein offers a rapid, sensitive, and useful way of detecting for micrometastasis to the regional lymph nodes in patients with non-small-cell lung cancer that is positive for p53 staining. The patients with such micrometastases have a poor prognosis and thus need to be carefully followed up after the initial pulmonary resection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9305185     DOI: 10.1016/S0022-5223(97)70178-8

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  12 in total

1.  Thoracoscopic right upper mediastinal dissection for left lung cancer.

Authors:  Katsunobu Kawahara; Takeshi Shiraishi; Akinori Iwasaki; Yasuteru Yoshinaga; Satoshi Yamamoto; Satoshi Yoneda; Takayuki Shirakusa
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-10

2.  Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival.

Authors:  Chun-Dong Gu; Toshihiro Osaki; Tsunehiro Oyama; Masaaki Inoue; Mantaro Kodate; Kazuhito Dobashi; Takeshi Oka; Kosei Yasumoto
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

3.  p53 gene mutations are not required for early dissemination of cancer cells.

Authors:  S Offner; W Schmaus; K Witter; G B Baretton; G Schlimok; B Passlick; G Riethmüller; K Pantel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

4.  Molecular biological markers and micrometastasis in resected non-small-cell lung cancer. Prognostic implications.

Authors:  T Osaki; T Oyama; M Inoue; C D Gu; M Kodate; M Aikawa; T So; M Mizukami; T Mitsudomi; K Yasumoto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-09

5.  [Significance of occult lymphatic tumor spread in pancreatic cancer].

Authors:  C Milsmann; L Füzesi; C Werner; H Becker; O Horstmann
Journal:  Chirurg       Date:  2005-11       Impact factor: 0.955

6.  Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors.

Authors:  C Milsmann; L Füzesi; E Heinmöller; P Krause; C Werner; H Becker; O Horstmann
Journal:  Langenbecks Arch Surg       Date:  2007-09-18       Impact factor: 3.445

7.  Significance of isolated tumor cells in lymph nodes among gastric cancer patients.

Authors:  Olaf Horstmann; Laszlo Füzesi; Peter M Markus; Carola Werner; Heinz Becker
Journal:  J Cancer Res Clin Oncol       Date:  2004-09-17       Impact factor: 4.553

8.  Detection of occult tumor cells in regional lymph nodes is associated with poor survival in pN0 non-small cell lung cancer: a meta-analysis.

Authors:  Zhicheng He; Yang Xia; Shaowen Tang; Yijiang Chen; Liang Chen
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

9.  Pretreatment identification of micro-metastasis in mediastinal lymph node by endobronchial ultrasound-guided transbronchial needle aspiration for early-stage non-small cell lung cancer-is it time yet?

Authors:  Abhishek Biswas; Michael A Jantz; Hiren J Mehta
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

10.  A novel differential diagnostic model for multiple primary lung cancer: Differentially-expressed gene analysis of multiple primary lung cancer and intrapulmonary metastasis.

Authors:  Dali Chen; Longyong Mei; Yubin Zhou; Cheng Shen; Huan Xu; Zhongxi Niu; Guowei Che
Journal:  Oncol Lett       Date:  2015-01-15       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.